Literature DB >> 15029259

Increased angiogenesis in cutaneous T-cell lymphomas.

Grzegorz Mazur1, Zdzisław Woźniak, Tomasz Wróbel, Joanna Maj, Kazimierz Kuliczkowski.   

Abstract

Primary cutaneous T-cell lymphomas (CTCL) represent a heterogeneous group of neoplasms derived from skin-homing T cells. CTCL behave similarly to indolent B-cell lymphomas. There is increasing evidence that angiogenesis may be important in lymphoproliferative disorders. The aim of the study was to evaluate microvessel density (MVD) as a parameter of tumor angiogenesis measured by the expression of CD34 in the skin samples in CTCL patients. Formaldehyde-fixed, paraffin-embedded skin tumor biopsy specimens from 25 patients (16 men, 9 women) with CTCL (mycosis fungoides), and 8 skin samples from healthy volunteers were analysed. The preparations were stained with haematoxylin and eosin, and evaluated histopathologically. Staining for endothelial cells with monoclonal antibody against CD34 revealed a mean number of 134 dots per mm2 for CTCL and 106 dots/mm2 for controls; the difference was statistically significant (p=0.0388). Our study shows a higher number of microvessels in primary CTCL compared with normal skin. Microvascular endothelial cells have become an important target in cancer therapy. Increased MVD in the skin of CTCL patients indicate that angiogenesis may play a role in the growth of CTCL, and raises the possibility of using angiogenesis inhibitors in CTCL therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15029259     DOI: 10.1007/BF02893406

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  13 in total

1.  Intratumoral microvascular density in malignant lymphomas of B-cell origin.

Authors:  B Ridell; K Norrby
Journal:  APMIS       Date:  2001-01       Impact factor: 3.205

Review 2.  Angiogenesis and angiogenic mediators in haematological malignancies.

Authors:  M H Mangi; A C Newland
Journal:  Br J Haematol       Date:  2000-10       Impact factor: 6.998

Review 3.  EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.

Authors:  R Willemze; H Kerl; W Sterry; E Berti; L Cerroni; S Chimenti; J L Diaz-Peréz; M L Geerts; M Goos; R Knobler; E Ralfkiaer; M Santucci; N Smith; J Wechsler; W A van Vloten; C J Meijer
Journal:  Blood       Date:  1997-07-01       Impact factor: 22.113

4.  Angiogenesis in cutaneous lymphoproliferative disorders: microvessel density discriminates between cutaneous B-cell lymphomas and B-cell pseudolymphomas.

Authors:  L Schaerer; M H Schmid; B Mueller; R G Dummer; G Burg; W Kempf
Journal:  Am J Dermatopathol       Date:  2000-04       Impact factor: 1.533

5.  Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9.

Authors:  A Vacca; S Moretti; D Ribatti; A Pellegrino; N Pimpinelli; B Bianchi; E Bonifazi; R Ria; G Serio; F Dammacco
Journal:  Eur J Cancer       Date:  1997-09       Impact factor: 9.162

Review 6.  Primary cutaneous T-cell lymphoma: review and current concepts.

Authors:  R S Siegel; T Pandolfino; J Guitart; S Rosen; T M Kuzel
Journal:  J Clin Oncol       Date:  2000-08       Impact factor: 44.544

Review 7.  Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies.

Authors:  A Vacca; D Ribatti; L Roncali; F Dammacco
Journal:  Leuk Lymphoma       Date:  1995-12

Review 8.  Mycosis fungoides and the Sézary syndrome.

Authors:  Y H Kim; R T Hoppe
Journal:  Semin Oncol       Date:  1999-06       Impact factor: 4.929

9.  Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study.

Authors:  D Ribatti; A Vacca; B Nico; M Fanelli; L Roncali; F Dammacco
Journal:  Eur J Haematol       Date:  1996 Jan-Feb       Impact factor: 2.997

Review 10.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

View more
  7 in total

1.  Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma.

Authors:  Thorbjørn Krejsgaard; Ivan V Litvinov; Yang Wang; Lixin Xia; Andreas Willerslev-Olsen; Sergei B Koralov; Katharina L Kopp; Charlotte M Bonefeld; Mariusz A Wasik; Carsten Geisler; Anders Woetmann; Youwen Zhou; Denis Sasseville; Niels Odum
Journal:  Blood       Date:  2013-06-25       Impact factor: 22.113

2.  Vascular endothelial growth factor-related pathways in hemato-lymphoid malignancies.

Authors:  Michael Medinger; Natalie Fischer; Alexandar Tzankov
Journal:  J Oncol       Date:  2010-05-24       Impact factor: 4.375

Review 3.  The role of angiogenesis in human non-Hodgkin lymphomas.

Authors:  Domenico Ribatti; Beatrice Nico; Girolamo Ranieri; Giorgina Specchia; Angelo Vacca
Journal:  Neoplasia       Date:  2013-03       Impact factor: 5.715

4.  Malignant T cells activate endothelial cells via IL-17 F.

Authors:  B Lauenborg; I V Litvinov; Y Zhou; A Willerslev-Olsen; C M Bonefeld; C Nastasi; S Fredholm; L M Lindahl; D Sasseville; C Geisler; M M Wasik; T Krejsgaard; L M R Gjerdrum; L Iversen; N Odum; A Woetmann
Journal:  Blood Cancer J       Date:  2017-07-21       Impact factor: 11.037

5.  Ki67 and CD31 Differential Expression in Cutaneous T-Cell Lymphoma and Its Mimickers: Association with Clinicopathological Criteria and Disease Advancement.

Authors:  Marwa Zohdy; Amal Abd El Hafez; Mona Younis Youssef Abd Allah; Hagar Bessar; Sherine Refat
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-06-23

Review 6.  Safety and danger of biologic treatments in psoriasis in context of cutaneous T-cell lymphoma (CTCL).

Authors:  Karol Kołkowski; Małgorzata Sokołowska-Wojdyło
Journal:  Postepy Dermatol Alergol       Date:  2021-10-25       Impact factor: 1.837

7.  Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma.

Authors:  Britt Lauenborg; Louise Christensen; Ulrik Ralfkiaer; Katharina L Kopp; Lars Jønson; Sally Dabelsteen; Charlotte M Bonefeld; Carsten Geisler; Lise Mette R Gjerdrum; Qian Zhang; Mariusz A Wasik; Elisabeth Ralfkiaer; Niels Ødum; Anders Woetmann
Journal:  Oncotarget       Date:  2015-06-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.